山中 龍也

論文

• Correction to: Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells.

  Ryosuke Osako, Azusa Hayano, Atsushi Kawaguchi, Ryuya Yamanaka

  Journal of neuro-oncology 2025年2月6日 査読有り最終著者責任著者
• Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells.

  Ryosuke Osako, Azusa Hayano, Atsushi Kawaguchi, Ryuya Yamanaka

  Journal of neuro-oncology 2024年12月5日 査読有り最終著者責任著者
• Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

  Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka

  International journal of clinical oncology 28(3) 468-481 2023年1月6日 査読有り最終著者責任著者
• Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

  Yasuo Takashima, Atsushi Kawaguchi, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka

  PloS one 16(6) e0251272 2021年 査読有り最終著者責任著者
• GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

  Yasuo Takashima, Momoko Hamano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Tsutomu Kobayashi, Hiroaki Hondoh, Ryuya Yamanaka

  Scientific reports 10(1) 8435-8435 2020年5月21日 査読有り最終著者責任著者
• Metabolome analysis reveals excessive glycolysis via PI3K/AKT/mTOR and RAS/MAPK signaling in methotrexate-resistant primary CNS lymphoma-derived cells.

  Yasuo Takashima, Azusa Hayano, Ryuya Yamanaka

  Clinical cancer research : an official journal of the American Association for Cancer Research 2020年2月27日 査読有り最終著者責任著者
• miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

  Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate, Hiroaki Hondoh, Junya Fukai, Koji Kajiwara, Azusa Hayano, Ryuya Yamanaka

  PloS one 15(2) e0229577 2020年 査読有り最終著者責任著者
• Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.

  Takashima Y, Kawaguchi A, Yamanaka R

  Cells 8(11) 2019年10月 査読有り招待有り最終著者責任著者
• Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

  Takashima Y, Yoshimura T, Kano Y, Hayano A, Hondoh H, Ikenaka K, Yamanaka R

  BMC cancer 19(1) 910 2019年9月 査読有り最終著者責任著者
• Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.

  Takashima Y, Kawaguchi A, Sato R, Yoshida K, Hayano A, Homma J, Fukai J, Iwadate Y, Kajiwara K, Ishizawa S …

  Scientific reports 9(1) 10004-10004 2019年7月 査読有り最終著者責任著者
• Concerns and Returns to Work in Patients with Breast Cancer Receiving Outpatient Chemotherapy: a Pilot Study.

  Tamura S, Sakaguchi K, Yamanaka R

  Asia-Pacific journal of oncology nursing 6(2) 187-192 2019年4月 査読有り最終著者
• Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells.

  Hayano A, Takashima Y, Yamanaka R

  International journal of clinical oncology 2019年4月 査読有り最終著者責任著者
• CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.

  Takashima Y, Kawaguchi A, Hayano A, Yamanaka R

  PloS one 14(5) e0216825 2019年 査読有り最終著者責任著者
• MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.

  Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R

  PloS one 14(1) e0210400 2019年 査読有り最終著者責任著者
• Frequency and risk factors for subsyndromal delirium in an intensive care unit

  Chikayo Yamada, Yoko Iwawaki, Kiyomi Harada, Michihiko Fukui, Masafumi Morimoto, Ryuya Yamanaka

  Intensive and Critical Care Nursing 47 15-22 2018年8月1日 査読有り最終著者責任著者
• Radiation-induced gliomas: a comprehensive review and meta-analysis

  Ryuya Yamanaka, Azusa Hayano, Tomohiko Kanayama

  Neurosurgical Review 41(3) 719-731 2018年7月1日 査読有り筆頭著者責任著者
• Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.

  Yasuo Takashima, Yasushi Sasaki, Azusa Hayano, Jumpei Homma, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Shin Ishizawa, Hiroaki Hondoh, Takashi Tokino …

  Oncotarget 9(44) 27471-27486 2018年6月8日 査読有り最終著者責任著者
• Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma

  Yasuo Takashima, Atsushi Kawaguchi, Tomohiko Kanayama, Azusa Hayano, Ryuya Yamanaka

  Oncotarget 9(27) 19065-19078 2018年4月10日 査読有り最終著者責任著者
• The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma.

  Miyasato Y, Takashima Y, Takeya H, Yano H, Hayano A, Nakagawa T, Makino K, Takeya M, Yamanaka R, Komohara Y

  Journal of clinical and experimental hematopathology : JCEH 58(2) 95-101 2018年 査読有り
• Effects and safety of mechanical bathing as a complementary therapy for terminal stage cancer patients from the physiological and psychological perspective: a pilot study

  Sawako Fujimoto, Yoko Iwawaki, Yukie Takishita, Yoko Yamamoto, Masako Murota, Saori Yoshioka, Azusa Hayano, Toyoshi Hosokawa, Ryuya Yamanaka

  JAPANESE JOURNAL OF CLINICAL ONCOLOGY 47(11) 1066-1072 2017年11月 査読有り最終著者責任著者